These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 38988566)

  • 1. Lomitapide repurposing for treatment of malignancies: A promising direction.
    Wu HT; Wu BX; Fang ZX; Wu Z; Hou YY; Deng Y; Cui YK; Liu J
    Heliyon; 2024 Jun; 10(12):e32998. PubMed ID: 38988566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting PP2A with lomitapide suppresses colorectal tumorigenesis through the activation of AMPK/Beclin1-mediated autophagy.
    Zuo Q; Liao L; Yao ZT; Liu YP; Wang DK; Li SJ; Yin XF; He QY; Xu WW
    Cancer Lett; 2021 Sep; 521():281-293. PubMed ID: 34509534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR.
    Lee B; Park SJ; Lee S; Lee J; Lee E; Yoo ES; Chung WS; Sohn JW; Oh BC; Kim S
    Cell Death Dis; 2022 Jul; 13(7):603. PubMed ID: 35831271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomitapide ameliorates middle cerebral artery occlusion-induced cerebral ischemia/reperfusion injury by promoting neuronal autophagy and inhibiting microglial migration.
    Zheng Y; Hu Y; Han Z; Yan F; Zhang S; Yang Z; Zhao F; Li L; Fan J; Wang R; Luo Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2183-2194. PubMed ID: 36052650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world safety and efficacy of lomitapide in homozygous familial hypercholesterolemia: interim report of special-use survey in Japan.
    Harada-Shiba M; Haruna S; Kogawa N
    Future Cardiol; 2024 Feb; 20(2):67-80. PubMed ID: 38420884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Lomitapide in Hypercholesterolemia.
    Liu X; Men P; Wang Y; Zhai S; Zhao Z; Liu G
    Am J Cardiovasc Drugs; 2017 Aug; 17(4):299-309. PubMed ID: 28255870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells.
    Saeed MEM; Boulos JC; Mücklich SB; Leich E; Chatterjee M; Klauck SM; Efferth T
    Cancer Genomics Proteomics; 2022; 19(5):540-555. PubMed ID: 35985681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide.
    Roeters van Lennep J; Averna M; Alonso R
    J Clin Lipidol; 2015; 9(4):607-17. PubMed ID: 26228681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.
    Sperlongano S; Gragnano F; Natale F; D'Erasmo L; Concilio C; Cesaro A; Golia E; Crisci M; Sperlongano R; Fimiani F; Russo M; Arca M; Limongelli G; Calabrò P
    J Cardiovasc Med (Hagerstown); 2018 Mar; 19(3):83-90. PubMed ID: 29389816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia.
    Tuteja S; Duffy D; Dunbar RL; Movva R; Gadi R; Bloedon LT; Cuchel M
    Pharmacotherapy; 2014 Mar; 34(3):227-39. PubMed ID: 24734312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.
    Stefanutti C
    Curr Atheroscler Rep; 2020 Jun; 22(8):38. PubMed ID: 32557261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.
    Mahzari M; Zarif H
    Adv Ther; 2021 May; 38(5):2159-2169. PubMed ID: 33829367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.
    Leipold R; Raal F; Ishak J; Hovingh K; Phillips H
    Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Therapy adherence,
    Kayikcioglu M; Ozkan HS; Yagmur B; Bayraktaroglu S; Vardarli AT
    Front Genet; 2022; 13():1087089. PubMed ID: 36685950
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide.
    Giammanco A; Cefalù AB; Noto D; Averna MR
    Curr Med Chem; 2020; 27(23):3773-3783. PubMed ID: 30663562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-targeting TACE/ADAM17 and gamma-secretase of notch signalling pathway in TNBC via drug repurposing approach using Lomitapide.
    Sen P; Kandasamy T; Ghosh SS
    Cell Signal; 2023 Feb; 102():110529. PubMed ID: 36423860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER).
    Underberg JA; Cannon CP; Larrey D; Makris L; Blom D; Phillips H
    J Clin Lipidol; 2020; 14(6):807-817. PubMed ID: 33023859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomitapide for the treatment of hypercholesterolemia.
    Berberich AJ; Hegele RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1261-1268. PubMed ID: 28598687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia.
    Davis KA; Miyares MA
    Am J Health Syst Pharm; 2014 Jun; 71(12):1001-8. PubMed ID: 24865757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
    Blom DJ; Fayad ZA; Kastelein JJ; Larrey D; Makris L; Schwamlein C; Bloeden L; Underberg J;
    J Clin Lipidol; 2016; 10(2):273-82. PubMed ID: 27055957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.